Change over period: —
NSE · INDRAMEDCO
INDRAPRAST
-34.7% from the 52-week high · +19.4% above the low
Indraprastha Medical Corp. Ltd. engages in the healthcare business. The company is headquartered in New Delhi, Delhi and currently employs 2,947 full-time employees. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The firm provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.
The short version. Promoter holding was 51.0% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
INDRAPRAST trades 34.7% below its 52-week high and 19.4% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.49 pts over 8 quarters.
Down 1.42 pts over 8 quarters.
+2 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 0.0 |
| FII | 2.88 | 2.94 | 2.72 | 2.41 | 2.73 | 2.44 | 2.77 | 2.39 | -0.49 |
| DII | 3.19 | 3.56 | 3.56 | 3.51 | 0.83 | 0.88 | 0.59 | 1.77 | -1.42 |
| Public | 42.93 | 42.51 | 42.72 | 43.08 | 45.44 | 45.69 | 45.64 | 44.84 | +1.91 |
Mutual fund holdings · Oct 2026
7 schemes hold this stock
5 the month before.
- ICICI Prudential Healthcare Fund0.83% of NAV
- Groww BSE Hospitals ETF0.62% of NAV
- Motilal Oswal BSE Healthcare ETF0.08% of NAV
- Bandhan BSE Healthcare Index Fund0.08% of NAV
- Motilal Oswal BSE 1000 Index Fund0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for INDRAPRAST are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about INDRAPRAST
What is the INDRAPRAST share price?
INDRAPRAST (INDRAMEDCO) last closed at ₹360.35, up 0.66% on the day. Its 52-week range is ₹299.80 to ₹548.15.
What is the market cap of INDRAPRAST?
INDRAPRAST has a market capitalisation of about ₹3,295 crore. Its price-to-earnings ratio is 17.2.
How are INDRAPRAST's latest results?
Promoter holding was 51.0% in Sep 2026, up 0.00 points over 8 quarters.
Who owns INDRAPRAST?
As of Sep 2026, shareholding was: Promoter 51.0%, FII 2.39%, DII 1.77%, Public 44.84%.
How many mutual funds hold INDRAPRAST?
7 mutual fund schemes held INDRAPRAST in October 2026. That compares with 5 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 18 Sep 2025 · Final Dividend - Rs. 4.5
- 13 Sep 2024 · Final Dividend - Rs. 4.5
- 15 Sep 2023 · Dividend - Rs. 3
- 15 Sep 2022 · Dividend - Rs. 2.5
- 12 Sep 2019 · Dividend - Rs. 1.6
- 12 Sep 2018 · Dividend - Rs. 1.5
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.